Department of Visceral, Transplant and Thoracic Surgery, Center for Operative Medicine, Medical University of Innsbruck, Innsbruck, Austria.
Interventional Oncology/Stereotaxy and Robotics, Department of Radiology, Medical University of Innsbruck, Innsbruck, Austria.
Transplantation. 2024 Jun 1;108(6):1410-1416. doi: 10.1097/TP.0000000000004997. Epub 2024 May 23.
Normothermic liver machine perfusion (NLMP) is advancing the field of liver transplantation (LT). Beyond improved preservation and organ assessment, NLMP helps to increase organ utilization. We herein address the feasibility and merit of NLMP in split liver transplantation (SLT) to postpone the transplantation of the second split graft to the following day.
We analyzed the perfusion characteristics and outcomes of all consecutive adult recipients who underwent SLT following NLMP from February 1, 2018, to June 30, 2023. The primary endpoint was 90-d graft and patient survival. Secondary endpoints were posttransplant complications and 90-d morbidity.
Three right and 3 extended right SLT following NLMP have been performed. NLMP was uneventful in all cases. Perfusion characteristics differed according to graft volume. Mean perfusion time was 17:00 h (±05:13) and bile production ranged between 8 and 21 mL/h. All split grafts fulfilled predefined center viability criteria during NLMP and were transplanted on the following day. The 90-d graft and patient survival rate was 100%. Three patients (50%) required an early relaparotomy, and 2 patients (33.3%) developed biliary complications. The 90-d morbidity as recorded by the comprehensive complication index was 62.7 (±24.7).
NLMP of split liver grafts is technically feasible and safe. Through prolongation of preservation time, NLMP allows to safely postpone transplantation of the second split liver graft to the next day.
常温机械灌注(NLMP)正在推动肝移植(LT)领域的发展。除了改善保存和器官评估外,NLMP 还有助于增加器官利用率。我们在此探讨了 NLMP 在劈离式肝移植(SLT)中的可行性和优势,以将第二个劈离肝移植物的移植推迟到次日。
我们分析了自 2018 年 2 月 1 日至 2023 年 6 月 30 日期间,所有接受 NLMP 后行 SLT 的成人受者的灌注特征和结局。主要终点是 90 天移植物和患者存活率。次要终点是移植后并发症和 90 天发病率。
3 例右半肝和 3 例扩大右半肝 SLT 后行 NLMP。所有病例的 NLMP 均顺利进行。灌注特征根据移植物体积而有所不同。平均灌注时间为 17:00±05:13,胆汁产量在 8 至 21ml/h 之间。所有劈离肝移植物在 NLMP 期间均符合中心预设的存活标准,并在次日进行移植。90 天移植物和患者存活率为 100%。3 名患者(50%)需要早期再次剖腹探查,2 名患者(33.3%)发生胆漏并发症。综合并发症指数记录的 90 天发病率为 62.7(±24.7)。
劈离肝移植物的 NLMP 在技术上是可行和安全的。通过延长保存时间,NLMP 可以安全地将第二个劈离肝移植物的移植推迟到次日。